Power3 Medical, Pwrm.ob, Aci, Abio, Adm
___
___
PWRM, Power 3 Medical Products Inc., PWRM.OB
PWRM is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimers disease, Parkinsons disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrigs disease).
PWRM recently delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro, Power3's diagnostic test, and focused on Power3's Alzheimer's disease blood serum biomarkers, test and clinical validation trials. Power3 has filed several patent applications for its NuroPro technology that are currently pending. Power3 also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas.
"In preparation for commercialization, our objective at this meeting was to show how Power3's protein biomarkers and blood tests provide superior solutions for diagnosis and drug response to improve the treatment of Alzheimer's disease," said Dr. Ira L. Goldknopf, Power3's President and Chief Scientific Officer. "It was gratifying to receive substantial attention to our posters from representatives of major pharma and clinical research institutions from around the world. They expressed surprise and enthusiasm for our findings, especially those relating to the methods by which Power3's protein biomarkers indicate how patients respond to treatment with the three major anti-dementia drugs."
LAST TRADE: 0.0251
VOLUME: 176,300
To learn more about visit: http://www.power3medical.com
********************
ARCA Biopharma, Inc. NasdaqGM: ABIO
ARCAs development of the first genetically-personalized cardiovascular therapybucindololis predicated on important discoveries in the field of cardiovascular genetics. ARCA has licensed diagnostic technology related to these discoveries from CardioDx, Inc., a leading company in the emerging field of companion diagnostics.
ARCA biopharma has an exclusive partnership with The Laboratory Corporation of America (LabCorp) to develop and commercialize a companion genetic diagnostic to aid in prescribing bucindolol, a genetically-personalized heart failure drug in development by ARCA. The new test identifies common genetic variations of the alpha-2c and the beta-1 adrenergic receptors that regulate the human heart. LabCorp is one of the worlds leading diagnostic laboratories.
ARCA biopharma, Inc., a biopharmaceutical company, focuses on the development and commercialization of genetically-targeted therapies for heart failure and other cardiovascular diseases in the United States. The company's lead product candidate is Gencaro, a pharmacologically beta-blocker and mild vasodilator for the treatment of chronic heart failure and other indications.
**************************************************
Arch Coal, Inc. (NYSE:ACI) announced recently that it again earned a spot on the InformationWeek 500, an annual listing of the nation's most innovative users of business technology. This marks the fifth consecutive year that Arch Coal has been ranked as one of the most innovative companies by InformationWeek. The 2010 list was announced last night at a gala awards ceremony held during the annual conference at the St. Regis Monarch Beach Resort in Dana Point, Calif.
Arch Coal earned a spot on the 2010 InformationWeek 500 list for its recent business intelligence implementation. Arch's business intelligence platform helps drive deeper and more sophisticated reporting and analysis by integrating company data from both legacy and off-the-shelf applications. Arch Coal is the only coal producer and one of only three natural resources companies among this year's InformationWeek 500.
St. Louis-based Arch Coal is the second largest U.S. coal producer. Through its national network of mines, Arch supplies cleaner-burning, low-sulfur coal to fuel roughly 8 percent of the nation's electricity. The company also ships coal to domestic and international steel manufacturers as well as international power producers.
********************
Archer Daniels Midland Company (NYSE: ADM) recently announced a donation of more than $1.3 million to support schools and educational initiatives in Macon County and throughout Central Illinois. The donation includes $260,000 for Decatur Public Schools, $250,000 for the Decatur Area Education Coalition and additional funds for schools and organizations in 16 Illinois counties.
The donation of more than $1.3 million is the single largest contribution ADM has made to support educational initiatives in Central Illinois. The donation was made through ADM Cares, the companys corporate social investment program. The donation of more than $1.3 million will be distributed by the Community Foundation of Decatur/Macon County to support several schools and organizations.
Every day, the 29,000 people of Archer Daniels Midland Company (NYSE: ADM) turn crops into renewable products that meet the demands of a growing world. At more than 240 processing plants, we convert corn, oilseeds, wheat and cocoa into products for food, animal feed, chemical and energy uses. We operate the worlds premier crop origination and transportation network, connecting crops and markets in more than 60 countries.
******************************************************************
For FREE Daily Stock Alerts & Updates Sign-up At: http://pennytobuck.com/signup
******************************************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer (http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and received an additional 1,000,000 shares 144 restricted stocks for a continuation of 6 months of advertisement and disseminating news, as well as $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB). Recently, Crown Equity Holdings, Inc has received an additional amount of 2,000,000 shares of free trading stock for 60 days media advertisement, web design and maintenance for Power 3 Medical Products Inc. (PWRM.OB)
by: Bill Pennyman
A Guide To The Medicine Ball Training Program Stock Alerts! From Pennytobuck.com - Power 3 Medical Products Inc., Pwrm.ob, Arch Coal Inc., Nyse:ac Simplify your emergency medicine coding The Numerous Ways For You To Stop Smoking Cigarettes Without Drugs Plenty Of Money In The Pocket With Medical Transcription What Medical Billing And Coding Training Can Do For Your Career Advisable To Take This Under Medical Supervision For Diet Pills Getting Help From The Best Drug Addiction Centers Cosmedicine Review Simplify Your Emergency Medicine Coding Anti-clotting Drug Plavix May Help Treat Lupus The Effect Of Driving Under The Influence Of Drugs Urgent-Medical-Care